Its mechanism of action mimics a natural hormone in the body, GLP-1, which plays a crucial role in glucose metabolism and appetite regulation
Food and Drug Administration approved semaglutide (Wegovy) to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease who have obesity or are overweight
Pregnancy Animal studies have shown potential risks to foetal development from semaglutide
Meaningful changes in body composition and recovery typically take several months of consistent use to become noticeable, and expecting overnight results often leads to disappointment
Meet with our team Shiva and our Los Gatos team review your facial anatomy, goals, and eligibility before recommending a plan
Adding GLP-1 or hormone coverage without a clinical support structure is an expense without a strategy